Treatment of Childhood-Onset Schizophrenia with Olanzapine
- 1 January 2000
- journal article
- clinical trial
- Published by Mary Ann Liebert Inc in Journal of Child and Adolescent Psychopharmacology
- Vol. 10 (2) , 69-78
- https://doi.org/10.1089/cap.2000.10.69
Abstract
This paper reports on a clinical observation of 15 hospitalized youths ages 6–13 years diagnosed with childhood-onset schizophrenia and acutely treated with olanzapine. Initial sedation was the most common side effect observed. Youngsters who had not had a previous trial on any psychotropic did better than those that had failed a previous medication trial. Age was inversely correlated with positive response to olanzapine. Patients who experienced initial sedation did best once the initial sedation wore off. The majority of patients in the study improved on olanzapine.Keywords
This publication has 6 references indexed in Scilit:
- Typical and Atypical Antipsychotics in Adolescent Schizophrenia: Efficacy, Tolerability, and Differential Sensitivity to Extrapyramidal SymptomsThe Canadian Journal of Psychiatry, 1998
- Frequency and Severity of Enlarged Cavum Septi Pellucidi in Childhood-Onset SchizophreniaAmerican Journal of Psychiatry, 1998
- Comment: Should we Walk before Setting the Pace?Australian & New Zealand Journal of Psychiatry, 1997
- Childhood-onset schizophrenia: biological markers in relation to clinical characteristicsAmerican Journal of Psychiatry, 1997
- Structural brain imaging in biological psychiatryBritish Medical Bulletin, 1996
- Childhood-Onset Schizophrenia: History of the Concept and Recent StudiesSchizophrenia Bulletin, 1994